3 completed, 1 not yet recruiting, 1 unknown. 5 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 5 | Completed 3, Not yet recruiting 1, Unknown 1 |
Follow Ipratropium Bromide: new trials by email Literature Review of Ipratropium Bromide trials Research Report on Ipratropium Bromide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Ipratropium Bromide on EILO Ipratropium Bromide, Normal Saline (Placebo) - Exercise-Induced Laryngeal Obstruction, Dyspnea During Activity | Phase 2 | Not yet recruiting | Cook Children's Health Care System | 50 | 2026-06-01 | 2026-05-05 |
| Treating Respiratory Emergencies in Children Study Ipratropium Bromide - Asthma in Children | Phase 2 | Completed | Oregon Health and Science University | 44 | 2024-01-19 | 2026-04-24 |
| Revefenacin in Acute Respiratory Insufficiency in COPD Revefenacin Inhalation Solution [Yupelri], Ipratropium Bromide - COPD, Acute Respiratory Failure | Phase 2 | Completed | University of California, Los Angeles | 21 | 2020-11-01 | 2026-10-14 |
| Ipratropium Bromide Spray as Treatment for Sialorrhea in Children Ipratropium bromide, Placebo - Sialorrhea | Phase 2 | Unknown | London Health Sciences Centre | 30 | 2019-01-01 | 2018-11-21 |
| Study to Investigate the Dose Response, Safety and Efficacy of Nebulized EP-101(SUN101) in Patients With Chronic Obstructive Pulmonary Disease (COPD): GOLDEN-1 Study EP-101 via nebulizer (eFlow®) 25 ug, EP-101 via nebulizer (eFlow®) 50 ug, EP-101 via nebulizer (eFlow®) 100 ug - Chronic Obstructive Pulmonary Disease | Phase 2 | Completed | Sunovion Respiratory Development Inc. | 140 | 2011-08-01 | 2018-05-09 |
Pulmonary Disease, Chronic Obstructive (2) · Sialorrhea (1)
Cook Children's Health Care System (1) · London Health Sciences Centre (1) · Oregon Health and Science University (1) · Sunovion Respiratory Development Inc. (1) · University of California, Los Angeles (1)
United States (4) · United Kingdom (1)
Ahmet Tutuncu, M.D., Ph.D. (1) · Donald Tashkin, MD (1) · Igor Z Barjaktarevic, MD, PhD (1) · Julie Strychowsky, MD (1) · Matthew L Hansen, MD, MCR (1)